Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Clinical trial NCT01457560 · COMPLETED

Trial details

NCT number: NCT01457560
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Acellular Pertussis Haemophilus Influenzae Type b Diphtheria Tetanus Poliomyelitis

Start date: 2000-02-01
Primary completion: 2001-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.